Background
Gray font color on white background Black font color on white background White font color on black background White font color on dark blue background
Font Size
News & Events » Media Stories
Print E-mail Bookmark Share This Page

PharmaLive - April 29, 2009 - Oxford BioMedica and Sanofi-Aventis Enter New Collaboration to Develop Gene-Based Treatments for Ocular Diseases

Oxford BioMedica (LSE: OXB) announced today that it has entered into a new collaboration with sanofi-aventis to develop novel gene-based medicines, utilising the Company’s LentiVector® gene delivery technology, for the treatment of ocular diseases.

To read more, click here.
 

Back to top

US Images

Chapters

Select a state from the dropdown below to view local chapters.


Free Information

Register here to receive free information about your eye condition and research efforts to find treatments and cures.

2012 Annual Report banner
VISIONS 2013 - Side Box banner
VisionWalk banner
View all
Events Calendar